The Scientist - Home

The money represents an increase of 6 percent over 1987, compared with a 4 percent rise in the government’s overall science budget. Sectors due to receive a reduced share of the $4.7 billion budget include research into the use of coal and other fossil fuels (down 10.5 percent) and nuclear fission technology (down 15.3 percent). Biotechnology (up 7.7 percent), oceanography (up 11 percent) and ecology (up 8 percent) are among the beneficiaries. Presenting his budget to the Bundestag, Re

LONDON—Embryo experimentation and the future of the fast breeder reactor are two of several topics that an Advisory Board for Science and Technology, due to be launched next month by the Parliamentary and Scientific Committee, will tackle to help inform U.K. members of Parliament. Seen as the first step toward a U.S-style Office of Technology Assessment, the new board will consist of four MPs, four members of the House of Lords and four members of the scientific community. Although so f

The Institute of Electrical and Electronics Engineers (IEEE) has adopted new voting procedures for choosing its top officers that are, in part, a response to continued pressure by dissident members to give the rank and file a greater voice in the institute’s affairs. In the fall the 280,000 member international organization will use a system that allows members to vote for more than one candidate for each office. Officials said that this system, called approval plurality voting, is the

LONDON—Over two-thirds of British people believe that national prosperity depends upon advances in science and technology, while 80 percent feel that it is important for the future of their country to be a leader in science. But a Gallup survey of more than 1,000 people also found that half of the respondents think that scientists are too secretive and that scientific discovery can pose dangers to humanity. Asked to name “the three most famous scientists, living or dead,” 3

LONDON—Cambridge and Oxford are the academic foci for new research programs that the British hope will make them more competitive in the expanding field of high-temperature superconductivity. The Cambridge group will be Britain’s first University Research Center. Bolstered by $10 million in government funds over the next six years, it is expected to attract private support and generate marketable products within 10 years. The URC will be a new university laboratory within the Cav

The strategic role of the private foundations Purnell Choppin observes in this issue (p. 16-17) that “the health of the biomedical research enterprise [in the United States] is inseparable from the health of the NIH.” Since two thirds of federal support for biomedical research in this country goes into or through the NIH, and since that amounts to one third of total national support for basic research in biomedicine, one can only agree with the statement of the president of the How

McDonald is on the staff of THE SCIENTIST.

Although such appropriations and bond issues promise to foster excellence throughout the state, the primary beneficiaries of much pump priming are usually state colleges and universities. These efforts, in turn, have triggered recruitment wars between established research institutions and newer programs trying to join the top echelon. The bidding is particularly fierce in such fields as ceramics, computers, chemical engineering and all aspects of biotechnology. And although higher salaries alo

LONDON-A major new trade union has emerged in Britain with the goal of organizing skilled workers in the new technologies. With trade union membership falling, the new organization, known as Manufacturing, Science and Finance (MSF), hopes to extend the frontiers of organized labor into areas where recruitment has been difficult. Its co-leaders, Clive Jenkins and Ken Gill, are confident that the new union can establish its identity quickly. MSF is the product of the merger of two medium-sized

Recent events have resulted in a great deal of publicity about competitiveness. Among the so-called races in high technology, the biotechnology race has attracted much attention and comment. In the United States, there is much concern about the perceived possibility that history may repeat itself, and that a technology that was invented in the United States may find its most impressive commercial applications developed in Japan. It is all very well to talk about competitiveness, not withstandi

STOCKHOLM--The Nobel Foundation plans to sell stock in a new firm being formed to preserve the value of the annual prizes it awards.. . . This year's prizes.. . will each be worth $340,000... . Shrewd investments in the past decade. . . have reversed years of declining value for the prizes, and have raised the foundation's assets to near the real value of the original estate in 1900. --From THE SCIENTIST October 5, 1987, p.4. Lend an ear to hear the story of my galloping success. I was onc

When I started Syntex Pharmaceuticals in Britain nearly a quarter of a century ago, the triumvirate to whom I reported in Mexico were all youngish scientists themselves, and all paper millionaires by their own remarkable efforts. The chairman of the corporation, George Rosenkranz, not only was one of the founders of the modern steroid industry, but he also had seen himself through the Eidgenössiche Technische Hochschule in Zurich by playing soccer for the Grasshoppers, acting at the Stadt